Работы, цитирующие эту работу

Работ: 3

Работа: Inhibitors of immune checkpoints—PD-1, PD-L1, CTLA-4—new opportunities for cancer patients and a new challenge for internists and general practitioners

1. Breast cancer vaccines; A comprehensive and updated review

   Sulieman Ibraheem Shelash Al‐Hawary, Ebraheem Abdu Musad Saleh, Nodirjon Akhmetovich Mamajanov +7

   Обзорная статьяImmunotherapy and Immune ResponsesPathology - Research and Practice2023Цитирований: 0

   ABIABI:AkademIndex/openalex/2023.review-article.000053

2. A comprehensive review of immunotherapy in gastrointestinal tumors with a focus on the role of combination therapy with PARP inhibitors

   Saade Abdalkareem Jasim, Jitendra Gupta, Subasini Uthirapathy +7

   Обзорная статьяCancer Immunotherapy and BiomarkersNaunyn-Schmiedeberg s Archives of Pharmacology2025Цитирований: 0

   ABIABI:AkademIndex/openalex/2025.review-article.000180

3. Emerging immune checkpoint targets and combination strategies in blood cancer immunotherapy

   Mutaz Jamal Al-khreisat, Waleed K. Abdulsahib, Ihsan Khudhair Jasim +6

   СтатьяCancer Immunotherapy and BiomarkersAnnals of Hematology2026Цитирований: 0

   ABIABI:AkademIndex/openalex/2026.article.009488